26 Jan 2018 San Mateo, CA – January 26, 2018: Adherium (ASX: ADR), a digital health company that improves medication adherence and patient outcomes, today announced Tim Houchin as Vice President of Sales. “Tim brings to our sales effort a sophisticated understanding of the intersection of wearables and healthcare as well as how to reach consumers […]
21 Dec 2017 San Mateo, CA – December 20, 2017: Adherium (ASX: ADR), a digital health company that improves medication adherence and patient outcomes, today highlighted milestones achieved in advance of 2018. “As we conclude December and the calendar year, we are accelerating realization of our vision of stronger partnerships between patients and physicians, facilitated by […]
Adherium today announced it has released SmartTurbo Model 4, the next generation of the company’s adherence monitoring technology, for AstraZeneca’s Turbuhaler medication. SmartTurbo Model 4 includes usability improvements to make the installation and removal of the Turbuhaler easier for older patients with COPD. The device also features a series of new larger buttons that help patients easily access new optional […]
04 Sep 2017 – link here We’re thrilled to announce that Adherium has received U.S. Food and Drug Administration (FDA) 510(K) clearance for its new SmartTouch for Symbicort® inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler. The SmartTouch for Symbicort® is a device installed onto a patient’s inhaler to monitor and encourage medication adherence as part of a self-management […]
9 June 2017:link here Adherium Limited (ASX : ADR), a global leader in digital health technologies that address sub-optimal medication use in chronic disease, today announced the appointment of Arik Anderson as Group Chief Executive Officer (CEO). Founder and past Group CEO, Garth Sutherland, welcomed the appointment of Arik as a key step in the […]
15/05/2017 – link here Adherium have come out on top at this year’s Hi-Tech Awards, claiming the coveted Hi-Tech Hardware Product award. Over 900 people attended the awards ceremony, which celebrates the successes of New Zealand hi-tech companies across 13 categories. In selecting Adherium as Most Innovative Hi-Tech Hardware Product, the international judges said, “Adherium has […]
By Heather Mack December 12, 2016 – link here SHARE 66 Melbourne, Australia-based smart inhaler company Adherium has been selected to supply the technology for a multi-country research program in Europe that will seek to establish whether home monitoring and mobile health tools can be used to manage asthma. Adherium’s Smartinhaler technology, which uses sensors to track […]
Melbourne, Australia, 21 April 2016. Link here.
30 September 2015. Link here. ..Three independent studies support the positive impact of Smartinhaler™ Platform in paediatric asthma. ..144% increase in adherence and 37% reduction in oral steroids indicating reduced severe exacerbations. ..Data disclosed at prestigious European Respiratory Congress in Amsterdam. ..Adds to data on Adherium’s SmartInhaler published in Lancet Respiratory Medicine Adherium Limited (ASX: ADR), […]
Media Release Monsoon Communications Digital health company’s technology improves adherence and patient health in chronic respiratory disease $35m maximum oversubscribed by Aust & international institutions & retail investors 26 August 2015: Digital health company Adherium Limited (ASX:ADR) listed on the Australian Securities Exchange today opening at 55 cents per share, a 10 per cent premium to […]